US laboratory test providers get break on "unfavourable" labelling rule
This article was originally published in Clinica
Executive Summary
US clinical laboratories that develop in-house tests or provide a laboratory testing service are free to add language that softens the potential negative effect of FDA-required disclosures appearing with lab results, the agency indicated this week.